As of June 21, 2025, Dong-E-E-Jiao Co Ltd (000423.SZ) reports a Current Ratio of 3.95.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Dong-E-E-Jiao Co Ltd's Current Ratio
Over recent years, Dong-E-E-Jiao Co Ltd's Current Ratio has shown a moderate pattern. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 3.95 |
| 2023-12-31 | 4.38 |
| 2022-12-31 | 4.66 |
| 2021-12-31 | 6.02 |
| 2020-12-31 | 7.46 |
This slight downward trend highlights how Dong-E-E-Jiao Co Ltd manages its short-term assets and liabilities over time.
Comparing Dong-E-E-Jiao Co Ltd's Current Ratio to Peers
To better understand Dong-E-E-Jiao Co Ltd's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Dong-E-E-Jiao Co Ltd (000423.SZ) | 3.95 |
| Chengdu Kanghong Pharmaceutical Group Co Ltd (002773.SZ) | 9.60 |
| Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357.SZ) | 9.05 |
| Wuhan Keqian Biology Co Ltd (688526.SS) | 5.34 |
| Zhejiang Xianju Pharmaceutical Co Ltd (002332.SZ) | 4.19 |
| Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS) | 4.16 |
Compared to its competitors, Dong-E-E-Jiao Co Ltd's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.